Colorado will be part of a 37-state, $90 million settlement with GlaxoSmithKline to resolve allegations that the drug manufacturer unlawfully promoted Avandia, a diabetes medication. Under the settlement, announced by Attorney General John Suthers, the state will receive $1.9 million in funds because the pharmaceutical company did not disclose all the medication’s negative side […]
This content is only available to members of the CSBJ. To gain access, you'll need to sign in or purchase Digital, Digital Partnership, Silver Membership, Print & Digital, Print, Digital and The Transcript or Digital Monthly If you're already a member, sign in here.